EASL Podcasts

Episoder

• 
  Talk Liver To Me - Africa’s Liver Crisis: Why Is No One Talking About It? 16.09.2026 40min

  Liver disease represents a major and under-recognised public health challenge across Africa, driven by a complex interplay of viral hepatitis, rising metabolic dysfunction-associated steatotic liver disease, and a high burden of hepatocellular carcinoma (HCC). Despite this, awareness, surveillance, and access to care remain limited. In this podcast, we explore the evolving epidemiology of liver disease across the continent, highlighting key drivers, regional variations, and gaps in diagnosis ...
• 
  EASL DeepDive: Utility and challenges of genetic testing in PFIC 14.09.2026 1t 3min

  This webinar explores the role of genetic testing in diagnosing Progressive Familial Intrahepatic Cholestasis (PFIC). Attendees will review key test types, understand the principles behind modern genomic technologies, and learn how to position these tests in the diagnostic approach of a person with a suspicion of PFIC and how to navigate common challenges in interpreting genetic results. The session will also highlight emerging trends shaping the future of genetic diagnostics in hepatology.&n...
• 
  Talk Liver To Me - What are the Dos and Don'ts in Acute Liver Failure? 02.09.2026 39min

  Acute liver failure (ALF) is a rare but life-threatening condition requiring rapid recognition and decisive management. Early decisions around investigation, escalation, and referral can significantly impact outcomes. Despite advances in care, variation in practice and avoidable pitfalls remain common. In this podcast, we take a practical, case-based approach to the key “dos and don’ts” in ALF management, focusing on early diagnosis, initial stabilisation, appropriate investigations, and time...
• 
  Talk Liver To Me - Endohepatology: Added value or added complexity? 19.08.2026 41min

  Endohepatology is emerging as a novel approach to liver disease assessment, with the potential to combine EUS-guided liver biopsy, portal pressure measurement, and variceal evaluation within a single session. This “one-stop shop” model could streamline diagnostic pathways and enable integrated, real-time clinical decision-making. However, this innovation comes at a time when hepatology is moving increasingly towards non-invasive testing strategies. Questions therefore remain around its approp...
• 
  Talk Liver To Me - What nobody tells you about starting a research group 05.08.2026 32min

  Early-career researchers and clinician-scientists play a central role in advancing hepatology research and innovation, yet the transition to independence often comes with challenges that extend beyond scientific expertise. Building a research programme, leading teams, securing funding, and developing a sustainable academic career require skills that are rarely addressed during formal training. In this podcast, we explore the realities of early academic leadership, focusing on the practical an...
• 
  Talk Liver To Me - Global Updates on Hepatitis E: How Should We Manage Acute and Chronic Infection? 22.07.2026 46min

  Hepatitis E is a globally prevalent infection with diverse clinical manifestations, ranging from self-limiting acute hepatitis to chronic infection in immunosuppressed patients. Its presentation and epidemiology vary significantly between regions, influencing diagnostic and management strategies. Despite increasing recognition, uncertainty remains around who to test, when to treat, and how to manage chronic disease effectively. In this podcast, we bring together perspectives from Europe and A...
• 
  Talk Liver To Me - MASLD and HFpEF: Do We Need a Shared Treatment Strategy? 08.07.2026 39min

  Metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure with preserved ejection fraction (HFpEF) are increasingly recognised as manifestations of a shared cardiometabolic disorder. Driven by overlapping risk factors such as obesity and insulin resistance, these conditions frequently coexist and may interact through liver–heart crosstalk. Despite this, they are typically managed separately, with limited disease-specific therapies and suboptimal outcomes. In this podc...
• 
  A joint EASL-ERN RARE-LIVER DeepDive – Wilson’s disease: a 2026 update 03.07.2026 1t 5min

  The following objectives will be addressed in this EASL Deep Dive episode: Have a profound knowledge of the pitfalls, limitations and difficulty of interpretation of the different tests of copper metabolism and liver copper assessmentsBe able to establish a diagnostic approach to Wilson’s disease, integrating clinical, laboratory, genetic and imaging toolsHave a good understanding of the different treatment modalities, how to position them in the disease course, how to monitor treatment and w...
• 
  Talk Liver To Me - Chasing the perfect SLD preclinical model 24.06.2026 34min

  Steatotic liver disease (SLD) research relies heavily on preclinical models, yet no single model can fully capture the complexity of human disease. In this episode, we explore the new EASL position paper on preclinical SLD models. From MASLD and MetALD to organoids and precision-cut liver slices, we discuss the strengths, limitations, and translational relevance of today's most widely used models. How do we choose the right model, and are we any closer to finding the perfect one? Based on EAS...
• 
  Talk Liver To Me - Haemochromatosis in 2026: Who Needs Testing and Who Needs Treatment? 10.06.2026 42min

  Haemochromatosis remains one of the most common inherited metabolic disorders, yet it is frequently underdiagnosed and inconsistently managed in clinical practice. With widespread use of iron studies and genetic testing, clinicians are increasingly faced with questions around interpretation, penetrance, and clinical significance. In this podcast, we explore current challenges in diagnosis and management, focusing on who should be tested, how to interpret results, and which patients benefit fr...
• 
  Talk Liver To Me - Liver Transplantation: Rise of the machines 13.05.2026 37min

  In this episode, we discuss the first pig-to-human liver xenotransplantation and the breakthroughs behind the revival of xenotransplantation, examining its potential and remaining challenges. We also explore the accelerating field of machine perfusion, clarifying different approaches and reviewing the evidence supporting their role in organ assessment, optimisation, and DCD utilisation. Host: Sarwa Darwish Murad (Erasmus University Rotterdam) Speakers: Jeroen de Jonge (Erasmus University Rott...
• 
  Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules? 29.04.2026 35min

  Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis - but rising antimicrobial resistance and emerging data are challenging long-standing practices. In this episode, we review current evidence on primary and secondary prophylaxis, resistance patterns, albumin use, and treatment strategies. How should clinicians balance prevention with antimicrobial stewardship? And where might practice need to evolve in 2026? Host: Thomas Marjot (King's College London) Speakers:&...
• 
  EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA) 23.04.2026 1t 7min

  In this EASL DeepDive webinar, the expert panel presents and explains the key studies behind the latest recommendations included in the EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma. Learning Objectives To identify patients at risk for eCCA, and review the current tools and strategies for its surveillance, diagnosis, staging, and classificationTo define the optimal candidates for resection and liver transplantation, and discuss challenges in the surgic...
• 
  Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible 15.04.2026 34min

  This episode explores the role of lifestyle in preventing and managing liver disease, including MASLD/MASH. Our experts discuss the impact of diet and physical activity, why lifestyle change can be difficult to start and sustain, and why small, achievable steps can still make a meaningful difference. Host: Cyrielle Caussy Speakers: Kate Hallsworth and Manuel Romero-Gómez This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-07
• 
  EASL DeepDive: Key Changes in the New EASL HBV Guidelines 09.04.2026 1t 16min

  In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of hepatitis B virus infection, published in the "Journal of Hepatology" in 2025. Learning objectives Understand the updated EASL recommendations for initiating and discontinuing antiviral therapy in chronic hepatitis B, including key differences with other HBV guidelines. Participants will be able to identify treatment indications and make informed decisions about when a...
• 
  EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis 09.04.2026 1t 19min

  In this EASL DeepDive, experts will discuss the latest advances in the EASL Clinical Practice Guidelines on the management of autoimmune hepatitis, published in the "Journal of Hepatology" in 2025. Learning objectives Select induction and maintenance treatment strategies aimed at achieving complete biochemical responseRecognise and manage disease flares, treatment intolerance, and suboptimal response in autoimmune hepatitisUnderstand tailored approaches to autoimmune hepatitis management in s...
• 
  EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies 09.04.2026 1t 15min

  Hepatocellular carcinoma (HCC) is responsible for 75% of all primary liver cancers and is the third most prevalent cause of cancer death worldwide, with 900,000 new cases diagnosed each year. Many patients are diagnosed at an advanced stage, making curative treatment difficult. In this DeepDive Webinar, you’ll be guided through the latest advances in hepatocellular carcinoma management, from the rising impact of immunotherapy combinations to evolving approaches in intermediate-stage disease.&...
• 
  Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss 01.04.2026 37min

  In this episode our speakers share their immediate impressions and break down the key highlights shaping the management of portal hypertension and advanced liver disease. What has truly changed in practice? Where was consensus reached and where do controversies remain? Tune in for a clear, practical overview of what you need to know from Baveno VIII. Host: Thomas Marjot Speakers: Mattias Mandorfer and Cristina Ripoll This episode is also available on EASL Campus: https://easlcampus.eu/t...
• 
  Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care? 18.03.2026 29min

  This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges. Host: Mattias Mandorfer Speakers: Marco Sanduzzi, Lorenza Rimassa This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-05
• 
  Talk Liver To Me - When Cure isn’t the only goal: Palliative Care in Advanced Liver Disease 04.03.2026 35min

  As deaths from advanced chronic liver disease rise, many patients never receive timely palliative care. In this episode, we explore why early, holistic support is essential in advanced liver disease and HCC, and unpack key recommendations from the new EASL Position Paper to help reduce suffering and improve quality of life. Host: Debbie Shawcross Speakers: Patrizia-Künzler-Heule, Sumita Verma This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-04